Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression

Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients

(2021) Xiaoyu Chen et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression

(2021) Mu-Hong Chen et al.   PSYCHOPHARMACOLOGY

Ketamine specifically reduces cognitive symptoms in depressed patients: An investigation of associated neural activation patterns

(2021) A. Stippl et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

(2021) Yan Wei et al.   MOLECULAR PSYCHIATRY

Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study

(2020) Mu-Hong Chen et al.   GENOMICS

Using classification and regression tree modelling to investigate treatment response to a single low-dose ketamine infusion: Post hoc pooled analyses of randomized placebo-controlled and open-label trials

(2020) Mu-Hong Chen et al.   JOURNAL OF AFFECTIVE DISORDERS

Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)

(2019) Mu-Hong Chen et al.   JOURNAL OF AFFECTIVE DISORDERS

The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review

(2018) Koen Demyttenaere et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion

(2018) Mu-Hong Chen et al.   JOURNAL OF AFFECTIVE DISORDERS

Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression

(2018) Yanling Zhou et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder

(2018) Wei Zheng et al.   JOURNAL OF AFFECTIVE DISORDERS

Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression

(2017) Tung-Ping Su et al.   NEUROPSYCHOPHARMACOLOGY

Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression

(2014) Paulo R. Shiroma et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial

(2014) James W Murrough et al.   NEUROPSYCHOPHARMACOLOGY

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

(2013) James W. Murrough et al.   AMERICAN JOURNAL OF PSYCHIATRY

Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder

(2013) Maura L. Furey et al.   JAMA Psychiatry

Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

(2010) Giacomo Salvadore et al.   NEUROPSYCHOPHARMACOLOGY